一个参数生存模型与贝叶斯结构方程基于多omics集成的参数生存模型
Jiadong Chu1, Yu Wang1,2, Na Sun3
1Department of Epidemiology and Biostatistics, School of Public Health, Medical College of Soochow University, Suzhou, 215123, China.
BMC bioinformatics
|November 29, 2025
概括
这项研究介绍了一种先进的贝叶斯结构方程模型,用于多omics生存分析. 这种新的框架通过整合各种omics数据来改善瘤发育预测,优于现有的方法.
科学领域:
- 在瘤学瘤学.
- 生物信息学是一种生物信息学.
- 统计建模 统计建模
背景情况:
- 多omics集成提供了关于瘤发育和预测建模的见解.
- 整合多样化的OMIC数据,特别是捕捉生物关系,仍然是一个挑战.
- 现有的结构方程模型在生存预测的多omics集成方面存在局限性.
研究的目的:
- 开发一个扩展的贝叶斯生存模型,与多omics数据的结构方程模型集成.
- 改进多个omics源的整合,以提高癌症研究中的预测准确度.
- 为了解决以前的模型在捕捉复杂的生物关系的局限性.
主要方法:
- 开发了一个扩展的贝叶斯生存模型与结构方程模型相结合.
- 无U转取样 (NUTS) 算法用于高效的后部分布采样.
- 该模型使用胃癌数据集与mRNA,microRNA和甲基化数据进行了验证.
主要成果:
- 拟议的模型在模拟中展示了出色的适合性和预测性能.
- 与非集成模型相比,对胃癌数据集的应用显示出优异的预测性能.
- 该模型在多omics生存分析中表现优于综合贝叶斯基因组学分析 (iBAG) 模型.
结论:
- 扩展的贝叶斯结构方程模型为多omics生存分析提供了一个强大的框架.
- 该模型通过捕捉跨欧米克数据的复杂生物关系,显著提高了预测准确性.
- 这种方法在非集成方法和现有的集成技术 (如iBAG) 上显示了明显的优势.
相关概念视频
Parametric Survival Analysis: Weibull and Exponential Methods
990
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
990
Assumptions of Survival Analysis
385
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
385
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
Introduction To Survival Analysis
714
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
714
Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Comparing the Survival Analysis of Two or More Groups
538
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
538


